雖然這篇evaluate-hf鄉民發文沒有被收入到精華區:在evaluate-hf這個話題中,我們另外找到其它相關的精選爆讚文章
[爆卦]evaluate-hf是什麼?優點缺點精華區懶人包
你可能也想看看
搜尋相關網站
-
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#1Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in ...
EVALUATE -HF was a multicenter randomized trial conducted at 85 hospital and clinic-based study sites in the United States.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#2EVALUATE-HF - American College of Cardiology
Description: The goal of the trial was to evaluate sacubitril/valsartan compared with enalapril among patients with heart failure and reduced ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#3Effect of Sacubitril-Valsartan vs Enalapril on Aortic ... - PubMed
... James C Fang , Joseph Izzo , Kevin McCague , Cheryl A Abbas , Ricardo Rocha , Gary F Mitchell , EVALUATE-HF Investigators ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#4Study of Effects of Sacubitril/Valsartan vs ... - ClinicalTrials.gov
Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction (EVALUATE-HF). The safety and scientific validity of this ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#5EVALUATE-HF: A study of aortic stiffness as a mechanism for ...
The EVALUATE-HF trial was a randomized, double-blinded multicenter trial of 464 patients with heart failure with reduced ejection fraction ≤40% randomized to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#6Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril ...
Treatment with sacubitril-valsartan in EVALUATE-HF was associated with a significant reduction in brachial pulse pressure that remained ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#7Commentary on the PROVE-HF and EVALUATE-HF Studies
... Prof Scott Solomon (Harvard Medical School, MA, US) and Prof Andrew Coats (University of Warwick, UK) discuss PROVE-HF and EVALUATE-HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#8JAMA - The PROVE-HF study and the EVALUATE-HF trial...
The PROVE-HF study and the EVALUATE-HF trial reported in this issue of JAMA together strongly suggest that ARNI therapy can promote cardiac reverse...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#9PROVE-HF and EVALUATE-HF - Novartis UK HCP Portal
ENTRESTO® (sacubitril/valsartan) clinical evidence of cardiac effects. For healthcare professionals only.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#10Early B-Type Natriuretic Peptide Change in HFrEF Patients ...
由 PL Myhre 著作 · 2022 — In an individual patient analysis from the EVALUATE-HF (Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#11PROVE-HF Trial Overview - American Journal of Managed Care
The first was called PROVE-HF, and the other was called EVALUATE-HF, and they both enrolled patients with heart failure with reduced ejection ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#12Study of Effects of Sacubitril/Valsartan ... - Novartis: Clinical trials
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction (EVALUATE-HF) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#13Entresto improved measures of heart structure and function in ...
“The PROVE-HF and EVALUATE-HF studies provide the first evidence that Entresto may help reverse the damage to the heart caused by HFrEF, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#14Sacubitril/Valsartan For Heart Failure & Ejection Fraction
PROVE-HF was an open-label study of 794 patients with chronic HFrEF assigned to sacubitril/valsartan and evaluated on echocardiography prior to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#15TRANSITION, PIONEER HF, EVALUATE-HF, PROVE-HF
PARADIGM-HF sonrası yayınlanan klinik çalışmalar: TRANSITION, PIONEER HF, EVALUATE-HF, PROVE-HF. Kütahya Sağlık Bilimleri Üniversitesi Tıp Fakültesi, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#16American College of Cardiology on Twitter: "ICYMI: The ...
ICYMI: The EVALUATE-HF trial failed to show that sacubitril was effective at reducing central aortic stiffness. https://bit.ly/2MruUR4 #ESCCongress #HFrEF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#17Hemodynamic Effects of Sacubitril–Valsartan vs Enalapril in ...
EVALUATE -HF randomized patients with EF ≤40 (HFrEF) to either ... and heart failure (HF) events in HF with reduced ejection fraction and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#18M ec hanisms of sacubitril– valsartan benefit in HFrEF - Nature
The evAluATe-Hf trial, which included 464 patients with. Hfref, assessed the effect of sacubitril–valsartan on central aortic stiffness and cardiac remodelling ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#19Timeline of laboratory procedures to evaluate HF-HRV ...
Download scientific diagram | Timeline of laboratory procedures to evaluate HF-HRV following stress (or neutral) imagery and smoking self-administration.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#20USING THE TEACH-BACK METHOD TO EVALUATE HF ...
USING THE TEACH-BACK METHOD TO EVALUATE HF. PATIENT EDUCATION: DOES IT WORK? D MacLeod, K Eastwood, C Struthers, C Jennings, N Rodger.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#21Sacubitril/Valsartan Does Not Significantly Increase BNP ...
... Mild to Moderate HF With Reduced Ejection Fraction (EVALUATE-HF; ... investigators evaluated changes in BNP among patients with HFrEF ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#22Evaluation of HF Radar Wave Measurements in Iberian ...
Evaluation of HF Radar Wave Measurements in Iberian Peninsula by Comparison with Satellite Altimetry and in Situ Wave Buoy Observations.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#23OUTSTEP‐HF: re‐evaluating the role of physical activity ...
OUTSTEP-HF: re-evaluating the role of physical activity measures in drug and device development in heart failure · Figures · References · Related ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#24Journal of Patient-Reported Outcomes - SpringerOpen
... used to evaluate the health status of patients with heart failure (HF) ... a safety net system to assess their perceptions of the KCCQ-12.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#25Impact of Sacubitril/Valsartan on Patient Outcomes in Heart ...
The EVALUATE-HF trial (Study of Effects of Sacubitril/Valsartan versus Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#26Novartis' Entresto Produces Mixed Results in Two Clinical Trials
EVALUATE -HF is a Phase IV, multicenter, randomized, double-blind, active-controlled trial to evaluate Entresto's effect on remodeling of the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#27First patient enrolled in CARE-HK in HF to evaluate role of ...
CARE-HK in HF is designed to evaluate the use of Veltassa® in enabling patients to remain on RAASi therapy in HF patients with or at high ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#28Sacubitril/valsartan promotes cardiac structure, function ...
In EVALUATE-HF, sacubitril/valsartan did not significantly reduce central aortic stiffness compared with enalapril, but was shown to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#29Sacubitril/valsartan versus angiotensin inhibitors and ...
for patients with HFrEF to assess for incremental benefit. ... demonstrated in the PARADIGM-HF trial.3 The latest ... EVALUATE-HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#30Use of sacubitril/valsartan in hospitalized patients with acute ...
logical therapy for chronic heart failure (HF) with reduced systolic function. ... The randomized, multicentre, double-blind EVALUATE-. HF21 Study, which ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#31james fang (0000-0003-2427-9504) - ORCID
Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#32HF Network Evaluation in the Alaskan Auroral Zone - IEEE ...
The Air Force is sponsoring a project to demonstrate and evaluate HF network performance in the Alaskan auroral zone. Automatic adaptive HF radio equipment ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#33AWAKE-HF - Journal of Cardiac Failure
AWAKE-HF: Rationale and Design of a Study Using a Wearable Biosensor to Objectively Evaluate the Effect of Sacubitril/Valsartan Initiation on Measures of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#34Open Access Articles - JACC: Heart Failure - Journals.Elsevier ...
Remote Speech Analysis in the Evaluation of Hospitalized Patients With Acute ... With Sacubitril/Valsartan A Pooled Analysis of EVALUATE-HF and PROVE-HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#35Novartis still hoping for Entresto success in heart failure with ...
EVALUATE -HF was a Phase IV trial investigating the effect of Entresto compared to enalapril on blood vessel remodelling and ventricular vascular ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#36:: iMRI :: Investigative Magnetic Resonance Imaging
To evaluate the effect of gadoxetic acid on the measurement of the ... In addition, it is important to evaluate HF not only for making the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#37Clinical Review: September 2-8
The drug was being evaluated in patients with heart failure with reduced ejection fraction (HFrEF). The trials were the PROVE-HF and EVALUATE-HF trials. PROVE- ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#38Research Letter - ABC Cardiol
Heart failure (HF) with reduced ejection fraction (HFrEF) leads to mortality and impairment ... treated with ARNI.8 In the EVALUATE-HF trial, which aimed to.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#39Angiotensin receptor-neprilysin inhibitor for the treatment of ...
Subsequent large-scale randomized trials have evaluated angiotensin receptor-neprilysin inhibitor in HF patients with acute decompensation ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#40What Underlies the Benefit of Sacubitril/Valsartan in HFrEF?
An exploratory analysis of the PROVE-HF trial of ... This prespecified exploratory analysis of PROVE-HF evaluated associations between ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#41Effects of ARNI treatment on arterial hemodynamics, cardiac ...
The EVALUATE-HF trial was set up to study the effects of sacubitril/valsartan treatment on cardiac and hemodynamic mechanisms, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#42Product Review Sacubitril/Valsartan (Entresto®) Update 2020 ...
... failure,7 and the recently published EVALUATE-HF and PROVE-HF trials,8,9 which investigated the effects of sacubitril/valsartan on cardiac remodelling.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#43Sacubitril-Valsartan, Clinical Benefits and Related ... - Frontiers
Heart failure (HF) is a clinical syndrome characterized by the ... effect in chronic patients was recorded in the EVALUATE-HF study: a ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#44Research Letter - SciELO
Heart failure (HF) with reduced ejection fraction (HFrEF) leads to mortality and impairment ... treated with ARNI.8 In the EVALUATE-HF trial, which aimed to.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#45Dapagliflozin in Patients with Heart Failure and Reduced ...
We designed the DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure) trial to prospectively evaluate the efficacy and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#46Objective - PLOS
Objective Heart failure (HF) and atrial fibrillation (AF) are often coexisting. ... trials (RCTs) evaluating the efficacy of sacubitril/valsartan in HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#47New Trial Results Demonstrate Potential of Entresto in ...
“The PROVE-HF and EVALUATE-HF studies provide the first evidence that Entresto may help reverse the damage to the heart caused by HFrEF, which ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#48Soluble urokinase-type plasminogen activator receptor ...
Our objective is to evaluate the suPAR prognosis performance in AHF patients on global mortality, risk of readmission after acute HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#49Entresto improved measures of heart structure and ... - Sign in
fraction (HFrEF) patients1; EVALUATE-HF results complement findings2 ... announced today results from two new clinical trials evaluating.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#50ACC pathway supports neprilysin inhibitor, SGLT-2 inhibitors ...
In addition, the randomized EVALUATE-HF (Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#51Evidence of superiority of sacubitril/valsartan versus ...
PANORAMA-HF study is the largest prospective ongoing HF trial conducted to assess whether S/V is superior to enalapril for treatment of HF ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#52Clarifying the Heart Failure Story: Data from PARAGON-HF ...
In the double-blind EVALUATE-HF trial, 464 patients with HFrEF (LVEF ≤40%) were randomized to sacubitril-valsartan or enalapril and evaluated ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#53重磅| 沙库巴曲缬沙坦改善HFrEF患者心脏结构,且耐受性良好
2019年欧洲心脏病学会(ESC)年会于当地时间8月31日-9月4日在法国首都巴黎召开。在此次会议上诺华分别发布了PROVE-HF和EVALUATE-HF两项研究数据,研究 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#54Discordance in LVEF Between Nuclear SPECT and ...
used to evaluate HF patients. Based on the current. 2013 American College of Cardiology/American Heart. Association (ACC/AHA) guidelines on management of.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#55Effect of Sacubitril-Valsartan vs Enalapril on Aortic ... - Meta
Akshay S DesaiEVALUATE-HF Investigators ... Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#56Patient & Physician Services Receive Healthcare Advertising ...
GOLD – Novartis EVALUATE-HF Enrollment Challenge Email Campaign. GOLD – UBC Animated Holiday Video. SILVER – UBC Video Services Marketing ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#57PARADIGM-HF sonrası yayınlanan klinik çalışmalar
PARADIGM-HF sonrası yayınlanan klinik çalışmalar: TRANSITION, PIONEER HF, EVALUATE-HF, PROVE-HF. . 2020; 3(2): 28-31. Corresponding Author: Mehmet Ali ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#58EMPEROR-HF: A phase III randomised, double-blind trial to ...
EMPEROR-HF: A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#59觀察某區域醫院ivabradine 治療慢性心衰竭病人的療效
LVEF left ventricular ejection fraction, HF Heart failure, DDI Drug-Drug interaction. ... This study was conducted to evaluate the impact indicators of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#60Clinical Research - Our Lady of the Lake Regional Medical ...
Study to Evaluate the Effect of GBT440 Administered Orally to Patients With Sickle Cell Disease. Purpose: The purpose is to assess ... Title: EVALUATE-HF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#61Incisive News in 3 Shots - PharmaShots
Search category · EVALUATE-HF · Novartis Reports Results of Entresto (sacubitril/valsartan) in Three P-III PARAGON-HF and P-IV PROVE-HF with EVALUATE-HF Studies f ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#62Sacubitril/valsartan for the management of heart failure
EVALUATE -HF investigators. Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#63Application of Capnography Waveform Analyses for ...
Proper utilization of these analyses could evaluate HF severity during the recovery process in patients with HF. Keywords. Capnography; Heart failure; ETCO2; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#64heart failure is not correlated with documented history of ...
echocardiographic evidence of HF. Indices used to evaluate HF with preserved ejection fraction (HFpEF) and heart failure with.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#65Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in ...
Novartis Pharmaceuticals, East Hanover, New Jersey. Mitchell GF. Cardiovascular Engineering Inc, Norwood, Massachusetts. EVALUATE-HF Investigators.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#66Exploring the Value of Mixed Methods Within the At Home ...
Target Population: The Housing First (HF) model is being implemented in ... Quantitative and qualitative methods were used to evaluate HF implementation.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#67The Effect of Gd-EOB-DPTA on the Stiffness Value of Magnetic ...
Purpose : To evaluate the effect of gadoxetic acid on the measurement of the stiffness value of MR elastography (MRE) used to evaluate hepatic fibrosis (HF) ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#68Family Caregiving for Individuals with Heart Failure - Scholars ...
... health, and well-being implications of caregiving in HF; (3) evaluate HF caregiving interventions to support caregiver and patient outcomes; ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#69REDUCE LAP-HF RANDOMIZED TRIAL II - Cleveland Clinic
Clinical Trials. REDUCE LAP-HF RANDOMIZED TRIAL II: A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#70Impact Education, LLC
Evaluate HF treatment guidelines and the applicability to a health-system ... Assess the impact of COVID-19 on HF management; Discuss racial and ethnic ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#71Mechanisms of Angiotensin-Receptor/Neprilysin Inhibition for ...
EVALUATE -HF did not conclusively illustrate how ARNI affected cardiovascular remodeling; the weak correlation between biomarkers and cardiac ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#72Novartis's heart failure drug Entresto presents mixed trial results
Novartis chief medical officer and global head of medical affairs Marcia Kayath said: “The PROVE-HF and EVALUATE-HF studies provide the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#73Diapositive 1
-DAPA HF,EVALUATE HF, PARAGON, GALACTIC. ○ Secondary Prevention: -THEMIS. ○ Coronary artery disease/Interventional cardiology:.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#74¿Es posible frenar y revertir el remodelado cardiaco con ...
Impacto de Sacubitrilo/Valsartán en el remodelado ventricular tras el PROVE-HF (1) y el EVALUATE-HF (2). PROVE-HF es un estudio prospectivo, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#75How popular drug helps in heart failure - ScienceDaily
The other study, called EVALUATE-HF, was led by Akshay S. Desai, MD, ... and echocardiography to assess cardiac structure and function.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#76Researchers uncover how popular drug helps in heart failure
Januzzi, MD, a physician in the Division of Cardiology at Massachusetts General Hospital (MGH). The other study, called EVALUATE-HF, was led by ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#77Entresto Improved Measures of Heart Structure and Function…
Results from PROVE-HF trial show significant improvements in measures ... ejection fraction patients; EVALUATE-HF results complement findings.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#78诺华Entresto治疗射血分数降低的心力衰竭(HFrEF)可改善 ...
2019年09月03日讯/生物谷BIOON/ --瑞士制药巨头诺华(Novartis)近日公布了两项新的临床研究PROVE-HF和EVALUATE-HF的结果。这些研究在射血分数降低的 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#79FATF Recommendations - Financial Action Task Force (FATF)
... combatting the financing of terrorism and proliferation (AML/CFT) standards, and the FATF Methodology to assess the effectiveness of AML/CFT systems.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#80Novartis announces positive results from two Entresto trials
The trials, evaluating the drug in patients with HFrEF, ... “The PROVE-HF and EVALUATE-HF studies provide the first evidence that Entresto ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#81Regulatory Inspector Human Factors Competency Framework
It includes HF competencies associated with safety management. ... Is able to evaluate the effect of HF on system performance. 3. Understand why errors.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#82Quality of Self-care Tied to Anxiety, Depression in HF
The questionnaires collected demographic information, self-care behavior, and religious attitudes, and were used to evaluate anxiety and ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#83Evaluating composite functions (video) | Khan Academy
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#84Corvia Medical's Atrial Shunt Evaluated in REDUCE LAP-HF II ...
The REDUCE LAP-HF II trial is a first phase III trial to evaluate an atrial shunt in heart failure patients to reduce HF symptoms, decrease HF- ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#85a randomised, multicentre, blinded, sham-controlled trial - The ...
REDUCE LAP-HF II is the first phase 3, randomised clinical trial to evaluate an interatrial shunt device in patients with heart failure, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#86Landmark REDUCE LAP-HF II Trial Demonstrates Clinical ...
The REDUCE LAP-HF II trial is the world's first phase III trial to evaluate an atrial shunt in heart failure patients to reduce HF symptoms, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#87Evaluation of Medicare Health Support Chronic Disease Pilot ...
ciaries with HF or diabetes mellitus with significant comorbidities—two prevalent and costly chronic conditions within the. Medicare FFS population.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#88H2FPEF Score for Heart Failure with Preserved Ejection Fraction
Related Calcs. MAGGIC Risk Calculator for HF · EHMRG Score · ITAS2010 for Takayasu Arteritis · Have feedback about this calculator? About the Creator.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#89Heart failure - Wikipedia
Heart failure (HF), also known as congestive heart failure (CHF) and (congestive) cardiac ... Echocardiography can also identify valvular heart disease and assess the ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#90A Review of Emerging ARNI Data in HFrEF, Radcliffe Cardiology
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#91Fabrication and Hemocompatibility Evaluation of a Robust ...
After being mechanically polished, the sample was acid-treated ultrasonically with a mixed acid solution (HF 0.66 wt % and HNO3 0.8 wt %) to ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#92Humanitarian Affairs Officer (Pooled Fund Manager), P4
Manage the OCHA Humanitarian Financing Unit (HFU) where the HF is ... ability to evaluate and integrate information from a variety of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#93landmark reduce lap-hf ii trial demonstrates clinical benefit of ...
The REDUCE LAP-HF II trial is the world's first phase III trial to evaluate an atrial shunt in heart failure patients to reduce HF symptoms, ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#942016 歐洲心臟學會心臟衰竭治療指引
心臟衰竭(heart failure, HF) 在定義上,. 是患者於臨床上有著典型心臟衰竭症狀( 表. 一),且可能伴隨著客觀之徵象( 表一),肇因. 於心臟功能上或結構上的異常而引起 ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#95Heart failure with mildly reduced ejection fraction - DocWire ...
ABSTRACTHeart failure (HF) is a complex clinical syndrome resulting ... to help cardiologists better evaluate and treat patients of HFmrEF.
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#96Influence of Mental Fatigue on Physical Performance, and Phy...
Previous studies have reported that the high-frequency (HF) component was ... This test was developed to specifically assess the physical performance of ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#97Risk factors for heart failure: A systematic review of prevalence ...
Additional studies that tackle co-occurring risk factors for HF ... Studies that systematically evaluate the prevalence and potential for ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#98What is Ejection Fraction? (HFrEF and HFpEF) - Heart Failure ...
Heart failure in young people · Tools used to assess quality of life · Myths and facts about heart failure · Heart failure causes and other common medical ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?> -
//=++$i?>//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['title'])?>
#99Preparation and Antibacterial Evaluation of Polyethylene ...
The release of silver from the formulation was also evaluated. ... Nowack, B., Krug, H. F., & Height, M. (2011). 120 years of nanosilver ...
//="/exit/".urlencode($keyword)."/".base64url_encode($si['_source']['url'])."/".$_pttarticleid?>//=htmlentities($si['_source']['domain'])?>
evaluate-hf 在 コバにゃんチャンネル Youtube 的最佳解答
evaluate-hf 在 大象中醫 Youtube 的最讚貼文
evaluate-hf 在 大象中醫 Youtube 的最佳解答